Abstract: Cationic contrast-enhanced computed tomography (CECT) capitalizes on increased contrast agent affinity to the charged proteoglycans in articular cartilage matrix to provide quantitative assessment of proteoglycan content with enhanced images. While high resolution microCT has demonstrated success, we investigate cationic CECT use in longitudinal in vivo imaging at clinical resolution. We hypothesize that repeated administration of CA4+ will have no adverse side effects or complications, and that sequential in vivo imaging assessments will distinguish articular cartilage repair tissue from early degenerative and healthy cartilage in critically sized chondral defects. In an established equine translational preclinical model, lameness and synovial effusion scores are similar to controls after repeated injections of CA4+ (eight injections over 16 weeks) compared to controls. Synovial fluid total protein, leukocyte concentration, and sGAG and PGE concentrations and articular cartilage and synovial membrane scores are also equivalent to controls. Longitudinal in vivo cationic CECT attenuation in repair tissue is significantly lower than peripheral to (adjacent) and distantly from defects (remote sites) by 4 weeks (p < 0.001), and this difference persists until 16 weeks. At the 6- and 8-week time points, the adjacent locations exhibit significantly lower cationic CECT attenuation compared with the remote sites, reflecting peri-defect degeneration (p < 0.01). Cationic CECT attenuation at clinical resolution significantly correlates with cationic CECT (microCT) (r = 0.69, p < 0.0001), sGAG (r = 0.48, p < 0.0001), and ICRS II histology score (r = 0.63, p < 0.0001). In vivo cationic CECT imaging at clinical resolution distinguishes fibrous repair tissue from degenerative and healthy hyaline cartilage and correlates with molecular tissue properties of articular cartilage.
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
Overview
This study evaluates the use of cationic contrast-enhanced computed tomography (CECT) for non-invasive, longitudinal imaging to differentiate between healthy, degenerative, and repair tissue in equine articular cartilage injuries.
It further assesses the safety of repeated contrast agent administration and correlates imaging results with molecular and histological markers of cartilage health.
Background and Purpose
Articular cartilage contains proteoglycans, which are negatively charged molecules critical for the tissue’s function and health.
Cationic contrast agents such as CA4+ have a positive charge that leads to preferential binding to these proteoglycans, allowing enhanced visualization of cartilage composition using computed tomography (CT).
Previous use of microCT with cationic agents has shown promise in detecting cartilage changes ex vivo at very high resolution.
The study aims to translate this approach for in vivo longitudinal imaging at clinical CT resolution, which is lower but more applicable for live animals or patients.
The hypothesis is twofold: repeated CA4+ injections are safe without causing harm, and in vivo CECT can reliably distinguish repair tissue from degenerative and normal cartilage in equine models of cartilage injury.
Methods
Used an established equine (horse) translational preclinical model with critically sized chondral defects (injuries involving cartilage only).
Monitored clinical signs such as lameness and synovial effusion (joint fluid swelling) to assess safety and adverse effects.
Collected synovial fluid samples to measure many biochemical markers:
Total protein concentration
Leukocyte (white blood cell) concentration
Sulfated glycosaminoglycan (sGAG) concentration — a key component of cartilage extracellular matrix
Prostaglandin E (PGE) concentration — related to inflammation
Histological scoring of articular cartilage and synovial membrane was performed post-mortem.
Longitudinal in vivo CECT imaging was conducted at multiple time points over 16 weeks and compared regions:
Repair tissue inside the defect
Adjacent cartilage surrounding the defect (peri-defect)
Remote cartilage distant from the defect
Correlated clinical resolution CECT attenuation with microCT results, biochemical sGAG content, and histological grading (ICRS II score).
Key Findings
Safety Assessment:
No significant differences in lameness or synovial effusion scores between treated and control joints.
Synovial fluid biomarkers (protein, leukocytes, sGAG, PGE) showed no adverse inflammatory or degradative changes due to repeated CA4+ administration.
Histological evaluation showed cartilage and synovial membrane integrity was maintained, supporting safety.
Imaging Results:
CECT attenuation in repair tissue inside defects was significantly lower than adjacent and remote areas starting as early as 4 weeks post-injury, persisting through 16 weeks.
Adjacent cartilage had lower attenuation than remote cartilage at 6 and 8 weeks, indicating early degenerative changes around the injury site (peri-defect degeneration).
Correlations and Validation:
CECT attenuation at clinical CT resolution correlated strongly with microCT (r=0.69), validating the imaging technique.
Positive but moderate correlations were found between CECT signal and biochemical sGAG content (r=0.48), confirming that imaging reflects molecular tissue composition.
Histology scores related to cartilage quality also correlated well with CECT attenuation (r=0.63), supporting clinical relevance.
Interpretation:
Lower attenuation in repair tissue reflects reduced proteoglycan content and fibrous rather than healthy hyaline cartilage formation.
Identifying peri-defect degeneration early may help guide clinical interventions.
CECT provides a non-invasive way to monitor cartilage repair quality and disease progression longitudinally.
Implications and Conclusion
The study demonstrates that repeated intra-articular injections of a cationic contrast agent in horses are safe and do not provoke adverse joint inflammation.
Longitudinal in vivo CECT imaging at clinical CT resolution can successfully differentiate repair tissue, degenerating cartilage, and healthy cartilage based on proteoglycan content.
This methodology allows for quantitative, non-destructive, and repeated monitoring of cartilage repair in a clinically relevant animal model.
Future applications may include improved diagnostics and treatment monitoring for joint injuries and osteoarthritis in both veterinary and human medicine.
Cite This Article
APA
Nelson BB, Mäkelä JTA, Lawson TB, Patwa AN, Snyder BD, McIlwraith CW, Grinstaff MW, Seabaugh KA, Barrett MF, Goodrich LR, Kawcak CE.
(2024).
Longitudinal in vivo cationic contrast-enhanced computed tomography classifies equine articular cartilage injury and repair.
J Orthop Res, 42(10), 2264-2276.
https://doi.org/10.1002/jor.25869
Orthopaedic Research Center, C. Wayne McIlwraith Translational Medicine Institute, Colorado State University, Fort Collins, Colorado, USA.
Mäkelä, Janne T A
Harvard Medical School, Beth Israel Deaconess Medical Center, Center for Advanced Orthopaedic Studies, Boston, Massachusetts, USA.
Department of Technical Physics, University of Eastern Finland, Kuopio, Finland.
Departments of Chemistry and Biomedical Engineering, Boston University, Boston, Massachusetts, USA.
Lawson, Taylor B
Harvard Medical School, Beth Israel Deaconess Medical Center, Center for Advanced Orthopaedic Studies, Boston, Massachusetts, USA.
Departments of Chemistry and Biomedical Engineering, Boston University, Boston, Massachusetts, USA.
Patwa, Amit N
Departments of Chemistry and Biomedical Engineering, Boston University, Boston, Massachusetts, USA.
Deparment of Chemistry, School of Science, Navrachana University, Vadodara, Gujarat, India.
Snyder, Brian D
Harvard Medical School, Beth Israel Deaconess Medical Center, Center for Advanced Orthopaedic Studies, Boston, Massachusetts, USA.
McIlwraith, C Wayne
Orthopaedic Research Center, C. Wayne McIlwraith Translational Medicine Institute, Colorado State University, Fort Collins, Colorado, USA.
Grinstaff, Mark W
Departments of Chemistry and Biomedical Engineering, Boston University, Boston, Massachusetts, USA.
Seabaugh, Kathryn A
Orthopaedic Research Center, C. Wayne McIlwraith Translational Medicine Institute, Colorado State University, Fort Collins, Colorado, USA.
Barrett, Myra F
Orthopaedic Research Center, C. Wayne McIlwraith Translational Medicine Institute, Colorado State University, Fort Collins, Colorado, USA.
Goodrich, Laurie R
Orthopaedic Research Center, C. Wayne McIlwraith Translational Medicine Institute, Colorado State University, Fort Collins, Colorado, USA.
Kawcak, Christopher E
Orthopaedic Research Center, C. Wayne McIlwraith Translational Medicine Institute, Colorado State University, Fort Collins, Colorado, USA.
MeSH Terms
Animals
Horses
Cartilage, Articular / diagnostic imaging
Cartilage, Articular / injuries
Contrast Media
Tomography, X-Ray Computed
Female
Cations
Male
Grant Funding
Päivikki ja Sakari Sohlbergin Säätiö
Suomen Kulttuurirahasto
Grayson-Jockey Club Research Foundation
College of Veterinary Medicine and Biomedical Sciences Cooperative Veterinary Scientist Research Training Fellowship, Colorado State University
William Fairfield Warren Distinguished Professorship
Orion Research Foundation
Finnish Cultural Foundation
References
This article includes 49 references
Bekkers JEJ, Creemers LB, Dhert WJA, Saris DBF. Review: diagnostic modalities for diseased articular cartilage‐from defect to degeneration: a review.. Cartilage 2010;1:157‐164.
Hayashi D, Roemer FW, Guermazi A. Imaging of osteoarthritis‐recent research developments and future perspective.. Br J Radiol 2018;91:20170349.
Taylor C, Carballido‐Gamio J, Majumdar S, Li X. Comparison of quantitative imaging of cartilage for osteoarthritis: T2, T1ρ, dGEMRIC and contrast‐enhanced computed tomography.. Magn Reson Imaging 2009;27:779‐784.
Bansal PN, Joshi NS, Entezari V. Cationic contrast agents improve quantification of glycosaminoglycan (GAG) content by contrast enhanced CT imaging of cartilage.. J Orthop Res 2011;29:704‐709.
Bansal PN, Stewart RC, Entezari V, Snyder BD, Grinstaff MW. Contrast agent electrostatic attraction rather than repulsion to glycosaminoglycans affords a greater contrast uptake ratio and improved quantitative CT imaging in cartilage.. Osteoarthritis Cartilage 2011;19:970‐976.
Lakin BA, Ellis DJ, Shelofsky JS, Freedman JD, Grinstaff MW, Snyder BD. Contrast‐enhanced CT facilitates rapid, non‐destructive assessment of cartilage and bone properties of the human metacarpal.. Osteoarthritis Cartilage 2015;23:2158‐2166.
Lakin BA, Grasso DJ, Shah SS. Cationic agent contrast‐enhanced computed tomography imaging of cartilage correlates with the compressive modulus and coefficient of friction.. Osteoarthritis Cartilage 2013;21:60‐68.
Lakin BA, Patel H, Holland C. Contrast‐enhanced CT using a cationic contrast agent enables non‐destructive assessment of the biochemical and biomechanical properties of mouse tibial plateau cartilage.. J Orthop Res 2016;34:1130‐1138.
Stewart RC, Bansal PN, Entezari V. Contrast‐enhanced CT with a high‐affinity cationic contrast agent for imaging ex vivo bovine, intact ex vivo rabbit and in vivo rabbit cartilage.. Radiology 2013;266:141‐150.
Stewart RC, Patwa AN, Lusic H. Synthesis and preclinical characterization of a cationic iodinated imaging contrast agent (CA4+) and its use for quantitative computed tomography of ex vivo human hip cartilage.. J Med Chem 2017;60:5543‐5555.
Orava H, Paakkari P, Jäntti J. Triple contrast computed tomography reveals site‐specific biomechanical differences in the human knee joint—a proof of concept study.. J Orthop Res Published online 2023.
Frisbie DD, Bowman SM, Colhoun HA, DiCarlo EF, Kawcak CE, McIlwraith CW. Evaluation of autologous chondrocyte transplantation via a collagen membrane in equine articular defects—results at 12 and 18 months. Osteoarthritis Cartilage 2008;16:667‐679.
Farndale R, Buttle D, Barrett A. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta—Gen Subj 1986;883:173‐177.
McIlwraith CW, Frisbie DD, Kawcak CE, Fuller CJ, Hurtig M, Cruz A. The OARSI histopathology initiative—recommendations for histological assessments of osteoarthritis in the horse. Osteoarthritis Cartilage 2010;18:S93‐S105.
Huttu MRJ, Puhakka J, Mäkelä JTA. Cell‐tissue interactions in osteoarthritic human hip joint articular cartilage. Connect Tissue Res 2014;55:282‐291.
June RK, Mejia KL, Barone JR, Fyhrie DP. Cartilage stress‐relaxation is affected by both the charge concentration and valence of solution cations. Osteoarthritis Cartilage 2009;17:669‐676.
Lippiello L, Hall D, Mankin HJ. Collagen synthesis in normal and osteoarthritic human cartilage. J Clin Invest 1977;59:593‐600.
Venn M, Maroudas A. Chemical composition and swelling of normal and osteoarthrotic femoral head cartilage. I. Chemical composition. Ann Rheum Dis 1977;36:121‐129.
Mainil‐Varlet P, Van Damme B, Nesic D, Knutsen G, Kandel R, Roberts S. A new histology scoring system for the assessment of the quality of human cartilage repair: ICRS II. Am J Sports Med 2010;38:880‐890.
Sande EPS, Martinsen ACT, Hole EO, Olerud HM. Interphantom and interscanner variations for Hounsfield units—establishment of reference values for HU in a commercial QA phantom. Phys Med Biol 2010;55:5123‐5135.
Bland JM, Altman DG. Calculating correlation coefficients with repeated observations: part 1—correlation within subjects. Br Med J (Clin Res Ed) 1995;310:446.
Burstein D, Velyvis J, Scott KT. Protocol issues for delayed Gd(DTPA)(2‐)‐enhanced MRI (dGEMRIC) for clinical evaluation of articular cartilage. Magn Reson Med 2001;45:36‐41.
Strickland CD, Ho CK, Merkle AN, Vidal AF. MR imaging of knee cartilage injury and repair surgeries. Magn Reson Imaging Clin N Am 2022;30:227‐239.
Lechuga L, Weidlich GA. Cone beam CT vs. fan beam CT: a comparison of image quality and dose delivered between two differing CT imaging modalities. Cureus 2016;8:e778.